On Saturday, October 13th, 2018, my primary doctor spoke for Penn Medicine’s Neuro-Ophthalmology 2018 update held at the Perleman Center for Advanced Medicine. The day led with a talk on optic neuropathy vs glaucoma followed by papilledema vs pseudopapilledema, eyelid disorders and diplopia. After the morning break, we listened to physicians speak about orbital inflammatory syndromes, neurodegenerative diseases, eye pain and neuro-ophthalmic emergencies.
Once the break for lunch had finished, the ophthalmologists and neurologists discussed pediatiric extra ocular disorders, thyroid eye disease, pseudotumor cerebri and clinical trials in neuro-ophthalmology before adjourning for the day. The thyroid eye disease segment was especially exciting, as it was announced that the Scheie Eye Institute will be opening at Thyroid Eye Clinic in November 2018. This service will combine neuro-ophthalmology with oculoplastics for the east coast’s first clinic dedicated solely to issues caused by thyroid dysfunction.
Aside from myself, one additional technician was in attendance, the rest being physicians. Ophthalmologists and Optometrists from Florida to Colorado traveled to Philadelphia for the event, which had been the first of its kind for Penn in ten years. The information presented was eye opening and I personally learned a great amount from the lectures. At the end of the day, I came out of this with over 20 pages of notes and a better understanding of the neuro-ophthalmology field. It is likely that I will not attend another conference like from Penn for another decade, but I am beyond happy that I was present for the occasion.
You can find out more about Penn Medicine’s Neuro-Ophthalmology Department at http://upno.org